Across TCGA pan-cancer cohorts, UTY Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated UTY data layer compared with 21 for mass-spec protein and 2 for mass-spec protein.

The strongest signal is observed in sarcoma (SARC), where higher UTY Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated UTY expression acts as an unfavorable survival marker.

SARC and COAD are the cancer types where UTY Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SARC	DFS	Median	All	0.086	0.611	<.001	12	view →
COAD	OS	Median	All	0.603	0.872	.029	2	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: UTY tumor-vs-normal RNA expression · all UTY data types